Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Whole Genome Microarray comparison of two Interferon Beta 1a Pharmaceutical Preparations

ABSTRACT: We have investigated the in vitro pharmacodynamic genomic effects of interferon beta 1a treatment on a whole genome microarray assay on lymphocytes from Multiple Sclerosis patients comparing the similarity between two biological products manufactured by two pharmaceutical companies. Keywords: Drug pharmacogenomics

ORGANISM(S): Homo sapiens

PROVIDER: GSE6692 | GEO | 2008/06/30

SECONDARY ACCESSION(S): PRJNA99075

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Pharmaceutical sludge

Project description:Pharmaceutical sludge Metagenome

| PRJNA509337 | ENA

Expression data of multiple sclerosis patients receiving intramuscular Interferon-beta-1a therapy [U133 A and B]

Project description:The purpose of this study was to characterize the transcriptional effects induced by intramuscular IFN-beta-1a treatment (Avonex, 30 µg once weekly) in patients with relapsing-remitting form of multiple sclerosis (MS). By using Affymetrix DNA microarrays, we obtained genome-wide expression profiles of peripheral blood mononuclear cells from 24 MS patients within the first four weeks of IFN-beta administration. Keywords: Multiple sclerosis, Interferon, Pharmacogenomics, Affymetrix

2009-12-03 | GSE19285 | GEO

Enterococcus mundtii 1A strain:1A

Project description:Enterococcus mundtii 1A strain:1A Genome sequencing

| PRJNA172933 | ENA

Escherichia coli 1A strain:1A

Project description:Escherichia coli 1A strain:1A Genome sequencing and assembly

| PRJNA224231 | ENA

Pharmaceutical degrading enrichment cultures

Project description:Pharmaceutical degrading enrichment cultures Raw sequence reads

| PRJNA782474 | ENA

Saccharomyces cerevisiae cells: W303-1A vs W303-1A delta MSN2, MSN4

2008-12-23 | GSE11878 | GEO

Activated sludge from Pharmaceutical industry

Project description:Activated sludge from Pharmaceutical industry Metagenome

| PRJNA509309 | ENA

Saccharomyces cerevisiae cells: W303-1A vs W303-1A delta MSN2, MSN4

Project description:Transcriptional profiling of Saccharomyces cerevisiae cells comparing the W303-1A wildtype with the W303-1A double mutant for MSN2 and MSN4 during zinc deficient conditions Keywords: Genetic modification with zinc limitation Two condition experiment, W303-1A vs W303-1A delta MSN2, MSN4. Biological replicates: 2 wildtype, 2 knock-out, independently grown and harvested.

2008-12-22 | E-GEOD-11878 | biostudies-arrayexpress

Pyrolobus fumarii 1A strain:1A

Project description:Pyrolobus fumarii 1A whole genome sequencing project.

| PRJNA48579 | ENA

Shigella flexneri 1a strain:1a

Project description:Shigella flexneri 1a str. 0439 Genome sequencing and assembly

| PRJNA356334 | ENA